CLR, RAMP2, and RAMP3 expressions have been reported in colorectal cancer; high levels of AM, CLR, RAMP2, and RAMP3 correlate with lymph nodes and distant metastasis, and a high level of AM correlates with a low disease-free survival [203,204]. This evidence concerns the gene RAMP3 and colorectal cancer.